Login to Your Account

RXi Acquisition of Apthera Builds Breast Cancer Assets

By Catherine Shaffer

Friday, April 1, 2011
A merger between Worcester, Mass.-based RXi Pharmaceuticals Corp. and Apthera Inc., of Scottsdale, Ariz., will round out RXi's portfolio of investigational immunotherapies, and give the company a much-needed boost into clinical development.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription